Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-025-00277-9. Article type: Review Article Keywords: Glutamate, Cannabis, Neuroimaging,…
Abstract Interest in preventative dietary interventions for human health has increasingly focused on the endocannabinoid (eCB)-like compound palmitoylethanolamide (PEA), a…
Abstract A combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) at non-psychoactive doses was previously demonstrated to reduce cognitive decline in…
Abstract There has been a significant increase in the consumption of cannabis for both recreational and medicinal purposes in recent…
Abstract Cannabidiol (CBD) appears to possess some neuroprotective properties, but experimental data are still inconsistent. Therefore, this in vitro study…
Abstract Objective(s): Alzheimer’s disease (AD) is a major public concern and one of the primary types of dementia characterized by…
Abstract Drug-resistant epilepsy (DRE) is associated with high extracellular levels of glutamate. Studies support the idea that cannabidiol (CBD) decreases…
Abstract Post-traumatic stress disorder (PTSD) is a psychopathological condition with a heterogeneous clinical picture that is complex and challenging to…
Abstract Introduction: Cannabis abuse during adolescence is a risk factor for cognitive impairments in psychiatric disorders later in life. To…
Abstract This study aimed to determine if orally administered cannabidiol (CBD) lessens the cortical over-release of glutamate induced by a…